<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0220650" disease_type="Neoplastic Process" abbrv="">Brain metastasis</z:e> (BM) is infrequent in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patients </plain></SENT>
<SENT sid="1" pm="."><plain>Although BM from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> is a late-stage phenomenon with an extremely poor prognosis, some subsets of patients would benefit from a multidisciplinary management strategy </plain></SENT>
<SENT sid="2" pm="."><plain>The prognosis of patients with BM from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> is associated with the curability of the therapy for BM and number of metastatic organs </plain></SENT>
<SENT sid="3" pm="."><plain>The start of chemotherapy treatment usually requires a delay of about 4 weeks after surgical resection in patients with primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> having synchronous distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>However, there is no evidence to indicate the required length of this delay interval </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, there is a chance that a patient may die because postoperative chemotherapy was not started soon enough and a <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic tumor</z:e> was able to develop rapidly </plain></SENT>
<SENT sid="6" pm="."><plain>Here, we present a case where combination chemotherapy with <z:chebi fb="0" ids="31348">capecitabine</z:chebi> and <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> (XELOX) was started within 1 week after resection of BM from <z:hpo ids='HP_0003003'>colon cancer</z:hpo> for synchronous multiple <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>To our knowledge, this is the first report of the start of chemotherapy, involving treatments such as folinic acid, fluorouracil, and <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> (FOLFOX); folinic acid, fluorouracil, and irinotecan (FOLFIRI); and XELOX within 1 week after resection of BM from <z:hpo ids='HP_0003003'>colon cancer</z:hpo> with synchronous multiple <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>These findings suggest possible changes in the start time of chemotherapy after surgery in the future </plain></SENT>
</text></document>